Human medicines European public assessment report (EPAR): Abevmy, bevacizumab, Date of authorisation: 21/04/2021, Revision: 14, Status: Authorised

Submitted by Anonymous (not verified) on 7 July 2026 - 15:40

Human medicines European public assessment report (EPAR): Abevmy, bevacizumab, Date of authorisation: 21/04/2021, Revision: 14, Status: Authorised

Opinion/decision on a Paediatric investigation plan (PIP): Yorvipath, palopegteriparatide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Endocrine disorders, PIP number: EMA/PE/0000241327

Submitted by Anonymous (not verified) on 7 July 2026 - 14:46

Opinion/decision on a Paediatric investigation plan (PIP): Yorvipath, palopegteriparatide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Endocrine disorders, PIP number: EMA/PE/0000241327

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness